Menopause Support
Menopause Support, licence 80147580: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- MenoSync, Menopause Balance
- Licence holder
- Health Bloom Inc.
- NPN or DIN-HM
- 80147580
- Status
- Active licence
- Licence date
- 3 March 2026
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Actaea racemosa L.: Seuls les extraits aqueux et hydro-alcooliques de titre faible (30 %) sont admis. La portion journalière recommandée ne doit pas conduire à une ingestion de glycosides de triterpène (calculés comme 27-déoxyactéine) supérieure à 3 mg.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Angelica sinensis Source : Angelica sinensis - Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 2000 mg Potency : 1.0 % Ligustilide | 200.0 mg | Not calculated |
| Actaea racemosa Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 mg Potency : 2.5 % Triterpene glycosides | 50.0 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. dulce Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 400 mg | 100.0 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Potency : 6.0 mg Formononetin | Not specified | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Potency : 6.0 mg Genistein | Not specified | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Trifolium pratense - sommité (herbe) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 3000 mg Potency : 6.0 mg Daidzein | 300.0 mg | Not calculated |
Non-medicinal ingredients
Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 18.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats). Source of (an) antioxidant(s)/Provides (an) antioxidant(s) that help(s) fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. (Used in Herbal Medicine to) help(s) relieve symptoms associated with menopause. Used in Herbal Medicine to help relieve the pain associated with menstruation as well as premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80147580
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.